Woman dies after drinking ‘medicine’ given to her by lover, his wife – Times Now

Pinky moved to rented accommodation in Thanesar's Akash Nagar area with her two children (Representative Image).   |  Photo Credit: iStock Images

Kurukshetra: A couple from Haryana's Kurukshetra allegedly fed poison to a woman. The woman had been living separately from her husband at a rented accommodation. The woman was found dead in Akash Nagar, Thanesar.

The deceased woman was identified as Pinky. Pinky hailed from the Bohli village in Kurukshetra.

Around 10 years ago, Pinky got married to Ravi. During the course of time, the couple became parents to two children. Around 3 years ago, Pinky took the decision of living away from her husband after he got addicted to drugs and moved out with her children.

Pinky moved to a rented accommodation in Thanesar's Akash Nagar area with her two children. She allegedly started having a relationship with a man identified as Ganga Singh. Ganga was an alcoholic. He used to assault Pinky and demanded money for alcohol. Pinky had recently opened up to her mother and informed her about the assault.

On August 8, Pinky's daughter Shabnam called her maternal uncle (Pinky's brother) Lakhan and said that Ganga and his wife had come to the house the previous day, The Times of India reported. Ganga and his wife allegedly made Pinky drink a medicine they had brought.

After consuming the medicine, Pinky started vomiting and died on Saturday. Mange Ram, SHO of Krishna Gate police station said, "The deceased woman's post-mortem has been conducted and the body handed over to the family for the last rites on Sunday. We have registered a case and started the investigation. The arrests are pending. " The accused were booked under relevant sections of the Indian Penal Code (IPC).

Follow this link:

Woman dies after drinking 'medicine' given to her by lover, his wife - Times Now

Global Precision Medicine Software Industry Market 2020 Size, Share, Trends, Growth and Outlook with Company Analysis and Forecast to 2025 – CueReport

The research report on Precision Medicine Software Industry market comprises of key development trends that define the industry in terms of profit potential and expansion scope. It also highlights the challenges & constraints that may negatively influence the market outlook alongside the various growth drivers and opportunities affecting the future remuneration of this business vertical. In addition, the study encompasses data regarding the impact of COVID-19 in an effort to gain insights about the projected performance over the study duration.

Major aspects from COVID-19 impact analysis:

Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/32342

A summary of the geographical landscape:

Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/32342

Other key aspects from the Precision Medicine Software Industry market report:

Major Points Covered in TOC:

Overview:Along with a broad overview of the global Precision Medicine Software Industry market, this section gives an overview of the report to give an idea about the nature and contents of the research study.

Analysis of Strategies of Leading Players:Market players can use this analysis to gain a competitive advantage over their competitors in the Precision Medicine Software Industry market.

Study on Key Market Trends:This section of the report offers a deeper analysis of the latest and future trends of the market.

Market Forecasts:Buyers of the report will have access to accurate and validated estimates of the total market size in terms of value and volume. The report also provides consumption, production, sales, and other forecasts for the Precision Medicine Software Industry market.

Regional Growth Analysis:All major regions and countries have been covered in the report. The regional analysis will help market players to tap into unexplored regional markets, prepare specific strategies for target regions, and compare the growth of all regional markets.

Segmental Analysis:The report provides accurate and reliable forecasts of the market share of important segments of the Precision Medicine Software Industry market. Market participants can use this analysis to make strategic investments in key growth pockets of the market.

Key questions answered in the report:

Request Customization on This Report @ https://www.cuereport.com/request-for-customization/32342

The rest is here:

Global Precision Medicine Software Industry Market 2020 Size, Share, Trends, Growth and Outlook with Company Analysis and Forecast to 2025 - CueReport

Letters: Virtual medicine is a COVID-era innovation worth keeping – The Advocate

If someone had sent me a Zoom meeting request last year, I would not have known what Zoom was, and I certainly would not have known how to join a virtual meeting. Flash forward to today, when I have three Zoom calls and am a pro at wearing collared shirts and sweatpants.

There is no denying that COVID-19 has increased the nations dependence on technology for communication. In particular, the pandemic has more or less forced the medical community to embrace virtual patient visits. As a medical and public health student, I initially struggled with the idea. As I saw the schedule of virtual visits, I snarked about the loss of the patient-physician relationship. I value looking my patient in the eye as he expresses his worry about his recent hearing loss influencing his profession as a pianist, noticing the subtle downturn of her lips as I suggest she cut back on her soda intake, appreciating the calluses of a woodworker as I perform my physical exam. But over time I realized that virtual visits have their advantages.

Virtual medical care increases health care access, protects those whose immune systems are compromised, and decreases anxiety about valued time lost to travel and missed work. For example, a young, working mother of three seeking a refill of her diabetes medication who had a physical exam and lab work at her OB-GYN appointment last week is a great candidate for a virtual visit. She does not have to find a babysitter and take off work yet again. An 84-year old man who just finished his second round of chemotherapy being seen for a mental health visit does not have to be exposed to the wealth of bacteria a clinic setting has to offer.

Moreover, patients tend to be more comfortable in the familiarity of their own homes. In one particular visit, I could almost feel a patients anxiety decrease as her shoulders settled from her ears to her chest, her relaxed mannerism flowing through the screen as I watched her Yorkie sniff around in the background.

I would be nave to state that virtual visits are superior to in-person visits, but they provide a valuable resource that should be embraced in certain situations post-COVID. Virtual visits provide a unique opportunity for patients and physicians alike, and thus should be an adaptation the medical community preserves post-pandemic. I hope that we as a medical community will continue to embrace virtual visits, realizing that sometimes a screaming toddler echoing in the background is an even trade for the time saved, comfort gained, and the availability of virtual medicine.

AMANDA RUSHING

MD/MPH candidate, LSUHSC New Orleans

Baton Rouge

More here:

Letters: Virtual medicine is a COVID-era innovation worth keeping - The Advocate

How Long Will Ben Simmons Be Out? Sports Medicine Expert Points To Patrick Mahomes Injury As Example Of Recovery Timeline – CBS Philly

PHILADELPHIA (CBS)- The Philadelphia 76ers announced Thursday that guard/forward Ben Simmons is out after an MRI showed a subluxation of the patella in his left knee. The team said in its statement that treatment options are currently being considered and further updates will be provided as appropriate.

That language can sound ominous, particularly for Sixers fans who have seen their star players lost to injury several times over the last few years. With the team in the Orlando bubble and set to begin the playoff push in a little over a week, the question of when or if Simmons could return looms.

The first question on fans minds, even those who have been following the injury-riddled Sixers through the years, is likely, what is a patella subluxation? As Dr. Brian Sennett, the Chief of Sports Medicine at Penn Medicine describes, a subluxation is basically a partial dislocation of the knee cap and therefore, usually less severe.

A subluxation is different from a dislocation in the sense that the knee cap does not go as far as you would see in a dislocation. It goes part way, but it never goes all the way. As a result, you often do not have the injury that you do with the dislocation and many of the times, you stretch the ligament but do not tear it, said Sennett. The bone bruises that you typically get with a dislocation, if they are even present, are a much lower magnitude. A patella subluxation is much less of an injury than a dislocation. A dislocation youre often going to be out for about six weeks. A patella subluxation, youre probably more in the range of 2-4 weeks.

Thats good news, but not exactly great news for fans hoping the Sixers can make a title run. Two weeks would bring Simmons back in time for the early part of the teams first-round series. On the longer side, four weeks would put him out through likely the first round and into the second, if the team were to make it that far.

However, Dr. Sennett points to Kansas City Chiefs quarterback Patrick Mahomes injury last year as a good point of comparison. Mahomes suffered a fully dislocated knee cap in Week 7. Normal recovery time, six weeks. But, Mahomes was able to return just three weeks later in Week 10 and then went on to win a Super Bowl.

Now, Mahomes own physiology played a part in that recovery. The timeline can vary depending on the athlete. Treatment for a subluxation, according to Dr. Sennett, is non-operative.

It typically is rehabilitation and surgery would only be indicated if it was a recurrent problem. Rehabilitation, regaining motion, regaining strength, controlling swelling and controlling pain with a return to athletics as soon as the athlete is comfortable and regained motion and strength, said Dr. Sennett. Then when come back youre typically treated with taping by the athletic trainer or with the use of a knee brace.

The Sixers stated that they are discussing treatment options with Simmons, and, of course, it will depend on when he feels comfortable, having regained the motion and strength in his knee. But, it remains possible that he could return to have an impact on the teams playoff run. Dr. Sennett does point out that once an athlete sustains this injury once, it is more likely to recur at some point. So, at the end of the season, he says, you will see some athletes decide to have surgery in order to lessen the likelihood of a recurrence.

It remains to be seen how the Sixers and Simmons will handle the injury, but there is a high likelihood that he will be able to return to his previous level of performance.

For now, the Sixers prepare for Thursdays matchup against the Orlando Magic with tip-off set for 6:30 p.m.

Excerpt from:

How Long Will Ben Simmons Be Out? Sports Medicine Expert Points To Patrick Mahomes Injury As Example Of Recovery Timeline - CBS Philly

Crozet Annals of Medicine: Strong Medicine – The Crozet Gazette

A deep weariness has settled into my bones. I feel like I am living the plot to the movie Groundhog Day, where every day is a repeat of the day before and nothing changes. It has been six months since the first COVID-19 case was diagnosed in the US and still we do not have a national plan to defeat this thing. I suppose waiting for a vaccine could be considered a plan, but we are going to lose a lot of people in the meantime.

A thousand people a day are dying in America of this thing, day in and day out. Over 160,000 dead, and counting. By November an estimated 250,000 or more Americans will have died of COVID.

So, I am tired, tired of the anxiety infecting my workplace, the fear of invisible contagion.

I am tired of the sense of abandonment that reusing disposable PPE engenders.

I am tired of seeing other countries doing so much better at this than us. With 4% of the worlds population we have almost 25% of the worlds deaths from COVID.

I am tired of leaving work exhausted and grimy only to see people gathering with no masks and no distancing. I dont like it when people with masks around their chins stand too close to me in the grocery store. At work in the ER I can instruct them in the proper fitting of a mask, but this seems problematic in Harris Teeter. Still, I am tempted.

I am tired of stripping off my scrubs and shoes on the front porch after work, before I can enter my home. Actually, I am not that tired of it. It is kind of liberating, but Ill bet the neighbors are getting tired of it. It is hard to remain a health care hero to your neighbors while in your underwear.

I am tired of the endless debate about whether our kids can go back to school. They cannot. They cannot because we could not stay out of bars, parties, and non-essential indoor activities this summer. Some of us refused to wear masks. As a result, case rates are now too high in most areas to open schools and are still rising in 34 states.

We can fix all of this, but it will take strong medicine.

The New England Journal of Medicine published some evidence-based guidelines this week for what it would take to get our kids back to school. I thought they were clear-eyed and useful, so I will share them with you.

1) The safest way to open schools fully is to reduce or eliminate community transmission while ramping up testing and surveillance.

2) Any region experiencing moderate, high, or increasing levels of community transmission should do everything possible to lower transmission.

3) The path to low transmission in other countries has included adherence to stringent community control measures including closure of nonessential indoor work and recreational spaces.

4) Such measures, along with universal mask wearing, must be implemented now in the United States if we are to bring case numbers down to safe levels for elementary schools to reopen this fall nationwide.

5) If such measures were adopted now, transmission in many states could probably be reduced to safe levels for mid-September or early-October school reopenings.

6) Many school districts would be able to open even sooner although large improvements in testing volume and speed of reporting would be needed to enable appropriate levels of community surveillance.

7) Adults who work in school buildings (or drive school buses) should be provided with PPE

8) Schools social and physical infrastructure will also need to be modified. Students and teachers may need to eat lunch in their classrooms, and staff rooms may need to be closed to discourage adult congregation.

Even if schools can make creative short-term use of additional space, thousands of schoolsparticularly those serving low-income students of colorwill require significant federally funded upgrades to improve ventilation, sanitation, nurses offices, and hand-washing and bathroom facilities.These improvements have long been needed regardless of Covid-19; they are essential investments in educational equity and opportunity.

But the fundamental argument that children, families, educators, and society deserve to have safe and reliable primary schools should not be controversial. If we all agree on that principle, then it is inexcusable to open nonessential services for adults this summer if it forces students to remain at home even part-time this fall.

So, there you have it. A national plan! My fatigue is lifting already.

Universal mask wearing.

Two months of lockdown.

Rapid and widely available testing.

Physically reconfiguring our schools.

I told you it would take strong medicine. But the sooner we start, the sooner we will fix this. A vaccine is simply not going to save us. We have to save ourselves.

Read more here:

Crozet Annals of Medicine: Strong Medicine - The Crozet Gazette

Advanced Therapy & Sports Medicine welcomes new PT – Great Bend Tribune

Advanced Therapy & Sports Medicine, Great Bend, announced the arrival of its newest team member, Dr. Dalton Jones, Physical Therapist. He joined Advanced Therapy in June.

In May 2017, Dr. Jones graduated from Pittsburg State University with Bachelors of Science in Exercise Science and Physics, as well as a minor in Public Health. Immediately thereafter, he attended Wichita State University, where in May 2020, he graduated with his Doctorate of Physical Therapy and began his career as a Physical Therapist here at Advanced Therapy and Sports Medicine.

Jones has lived all over Kansas, from the southeast to the northwest corner of the state, and now resides in Otis. His favorite part of being a physical therapist is meeting new people every day and learning from them. In his free time, he enjoys hunting, fishing, metal detecting and playing the guitar.

He is accepting new patients and is eager to meet more of the community and enhance their health and wellbeing.

Read this article:

Advanced Therapy & Sports Medicine welcomes new PT - Great Bend Tribune

Schwazze, Formerly Operating as Medicine Man Technologies, Inc., to Host Second Quarter 2020 Conference Call and Webcast on August 13, 2020 – Business…

DENVER--(BUSINESS WIRE)--Schwazze, formerly operating as Medicine Man Technologies Inc. (OTCQX: SHWZ) ("Schwazze " or the Company"), today announced that it will host its second quarter 2020 conference call and webcast on Thursday, August 13, 2020 at 4:30 p.m. ET.

Investors interested in participating in the conference call can dial 201-389-0879 or listen to the webcast from the Company's Investors website at https://ir.schwazze.com. The webcast will later be archived as well.

Following their prepared remarks, Chief Executive Officer Justin Dye and Chief Financial Officer Nancy Huber will also answer investor questions. Investors may submit questions in advance or during the conference call itself through the weblink: http://public.viavid.com/index.php?id=140284. This weblink has also been posted to the Companys Investors website.

About SchwazzeMedicine Man Technologies, Inc. is now operating under its new trade name, Schwazze. Schwazze is executing its vision to become one of the nations largest vertically integrated cannabis holding companies by revenue. Upon the completion of its announced acquisitions, its portfolio will consist of top-tier licensed brands spanning cultivation, extraction, infused-product manufacturing, dispensary operations, consulting, and a nutrient line. Schwazze leadership includes Colorado cannabis leaders with proven expertise in product and business development as well as top-tier executives from Fortune 500 companies. As a leading platform for vertical integration, Schwazze is strengthening the operational efficiency of the cannabis industry in Colorado and beyond, promoting sustainable growth and increased access to capital, while delivering best-quality service and products to the end consumer. The corporate entity continues to be named Medicine Man Technologies, Inc.

Forward-Looking StatementsThis press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control and cannot be predicted or quantified. Consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; and (v) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Go here to read the rest:

Schwazze, Formerly Operating as Medicine Man Technologies, Inc., to Host Second Quarter 2020 Conference Call and Webcast on August 13, 2020 - Business...

Penn Medicine-Led Research Suggests Greater Access to Specific HIV and Tuberculosis Medications is Needed Worldwide – Newswise

Newswise PHILADELPHIA After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB. While the treatments associated with lower mortality risk are common in the United States and are recommended by the WHO as the best treatment for these patients, global accessibility varies widely. The findings, which were published today in The Lancet, suggest that every effort should be made to quickly bring these life-saving medications to those in need.

In the largest individual patient data meta-analysis study to assess mortality risk of people with both HIV and multi-drug resistant TB, scientists first compared the risk of death for HIV-positive people versus HIV-negative people, then examined how receiving ART and different types of TB drugs altered this risk. Because of the large sample size, associations of specific TB drugs with mortality were evaluated, focusing on the most effective drugs, categorized as Group A by the World Health Organization (WHO). Data from 52 studies and 37 different countries was used, and the investigators controlled for things like age, the wealth of the region in which the individuals lived, and severity of drug resistance. Researchers ultimately found that while patients with HIV infection were at higher risk of death, this risk was reduced substantially when Group A TB drugs and ART were used. As there are various types of Group A TB medications, the odds survival varied based on which Group A medication or combination was employed. When looking at only those with HIV, the risk of death was reduced by over 80% with use of specific TB drugs.

Previous smaller studies had suggested these associations, but the large scale of this study solidifies the importance of using ART and the WHO Group A TB medications such as later-generation fluoroquinolones, bedaquiline, and linezolid to treat those who both have drug-resistant TB and are also HIV positive, said lead author Gregory Bisson, MD, MSCE, an Infectious Diseases specialist and an associate professor of Medicine at Penn. In addition, using mortality as a measure of whether this treatment was effective offered clear answers as to just how valuable these medications are.

Having both tuberculosis and HIV is not uncommon. Multi-drug resistant TB affects roughly half a million people around the world every year according to the WHO. And of all those with TB, about 9 percent are also HIV positive. It is not surprising since HIV makes people more susceptible to all kinds of infections, like TB, as well as viral and fungal infections, Bisson said. But the reason patients in need dont often receive effective treatments for one or both of the conditions is mostly due to accessibility.

The availability of ART and the most effective TB medications often depends on where patients live, Bisson said. Previous studies have found that in some regions only a third of patients with drug-resistant TB access effective treatment. Given the associations with mortality we found in this study, there should be urgency in the medical community to find ways to make these medications more affordable and available.

While ART has been found to decrease risk of death when given during treatment of drug-sensitive TB, there has been less evidence indicating this is the case in the more complex case of highly-drug resistant TB disease, Bisson said. Hesitance to use ART when patients are on several drugs for drug-resistant TB may also come from the potential toxicity of ART medications. Negative effects from ART can range from neuropathy to a rash and central nervous system toxicity. While Bisson agrees that ART medications may have adverse effects, their benefits far outweigh their risks including in drug-resistant TB.

Bissons research lays a foundation to further investigate the success of specific ARTs in conjunction with TB medications. It also allows the medical community to study methods that might bring these treatments to those who have trouble affording them or accessing them where they live.

Penns Jonathan Walsh also authored this study.

More here:

Penn Medicine-Led Research Suggests Greater Access to Specific HIV and Tuberculosis Medications is Needed Worldwide - Newswise

Cubs now aiming to play – Medicine Hat News

By RYAN MCCRACKEN on August 8, 2020.

rmccracken@medicinehatnews.com

The Medicine Hat Cubs shifted focus to the future at Thursday nights annual general meeting electing an almost entirely new board and signaling a desire to remain in the Heritage Junior Hockey League for the 2020-21 season.

Back in June, the Cubs announced they would not be icing a team for the upcoming campaign due to diminishing sponsorship revenues brought on by the COVID-19 pandemic, but newly elected board member and head scout Troy Sandau says he feels that decision was made prematurely.

That was on the old board, now with a bunch of new faces we hope to reverse that and hopefully have a team going this year, said Sandau. With COVID going on, we are kind of handcuffed by a few things but we want to have a season and the kids want to be on the ice. Were going to work hard and follow the guidelines for the health and safety first and foremost of the players. We just want to field a team this year. Financially, I think well be alright.

Cubs general manager Dave Kowalchuk confirmed Thursday evening that the team can re-enter the HJHL for the 2020-21 season. The Cubs even announced a new signing Friday morning in the form of 17-year-old defenceman Levi Brewer.

We have a meeting again with the league on (Aug. 10) and they want to know if were a go or not, said Kowalchuk. We did have a meeting with the league last week regarding what the schedule will look like. Right now, technically were looking at an Oct. 28 start, 30-game season.

It was a somewhat contentious AGM at First Assembly of God Church in Medicine Hat, as disputes about the clubs financial statement and the general direction of the team caused a stir among the roughly 50 people in attendance.

The teams three-page financial statement presented a June 1 2019 opening balance of $7,092.26, followed by $3,092.93 net income over the ensuing season and a new balance of only $3,092.93 on June 1 2020.

After a lengthy discussion on the topic, members approved a motion to conduct an immediate external audit.

There needs to be some paperwork. There needs to be some financial accountability, said newly elected board member Dale Roth. When the folks in the crowd at an AGM are saying, Well wait a minute the numbers dont make sense, and they legitimately dont make sense, thats one of the key things that we have to get on as a society.

Roth added hes been involved in hockey at various levels for decades and believes he can help steer the team in a positive direction.

A buddy of mine said, You know what? The Cubs could use some help. They could use a guy like you that knows how to market the game, that knows how to be part of social media, that knows the media in Medicine Hat and can help sell the game and get sponsorship and get the community back involved, he said. If dollars are an issue, well, well reach out to the community and give them a product on the ice that Medicine Hat can once again be proud of and put their money behind.

A bylaw change was also passed at the AGM to reduce the maximum size of the board from 12 to eight. Eleven were nominated Thursday, prompting a vote that ultimately elected Roth, Sandau, Lorrie Stadnicki, Deb Wickham, Justin Crawford, Glenn Stahl, Jerry Straub and Donna Schlosser.

Of the eight members elected to the board, only Crawford returns from the previous season. Outgoing president Richard Fritzler said he was glad he wasnt nominated to return to his role, as he would have declined.

I enjoyed the two-and-a-half years I put in, I enjoyed the players and riding the bus with them, said Fritzler. Id like to thank the old members on my board for all their hard work. We did have some exciting things going on but I guess that wont happen now. I wish the Cubs all the best of luck in the future, and the new board.

The new board will establish roles of president, vice-president, secretary and treasurer at its first meeting, which will take place Sunday on Zoom.

Hockey operations still has a good deal of ground to cover as well. The team parted ways with co-coaches JD Gaetan and Steve Leipert in the off-season and have yet to fill the vacant positions. Kowalchuk says he has a few leads on potential bench bosses, as well as new players evidenced by Fridays signing of Brewer.

Over the past few months here Ive reached out to some ex-coaches from the SJHL, AJHL, he said. I know there are some local guys that are interested as well, they havent really reached out to me but Ive had some emails coming through, some resumes.

The High River Flyers are the only other HJHL team to opt out of the upcoming season, which could present an opportunity for the Cubs as they look to rebuild a roster. However, Kowalchuk says players who had previously committed to return to the Cubs from last season still intend to play in Medicine Hat if there is a team, as long as they dont reach a higher level in the meantime.

Were pretty good between the pipes, defensively we should be pretty good as well, said Kowalchuk. We just got word that Cooper Hilworth (forward) will be going to Nanaimo Clippers camp in B.C., but if he doesnt make it hell definitely be back here in September to start skating.

The Cubs also paid tribute to three alumni who recently passed away, BJ Niwa, Mike Engel and Ryan Pancoast, with a moment of silence to begin Thursdays AGM.

You must be logged in to post a comment.

Read the rest here:

Cubs now aiming to play - Medicine Hat News

Why doctors and researchers need access to hydroxychloroquine | TheHill – The Hill

On July 6, a team of doctors from Henry Ford Hospital, supported by physicians from Baylor University Medical Center, submitted an urgent request to the Food and Drug Administration (FDA) to reauthorize use of hydroxychloroquine (HCQ) for early treatment of COVID-19. Since that day, more than 25,000 more Americans have died from the virus as COVID-19 continues to burn through communities across America. If the results of a recent Henry Ford Hospital study are accurate, at least half of these patients might have been saved by HCQ.

Since the pandemic from China first hit America with brute force early in March, it has become apparent to physicians that the medicine works best when as with any anti-infective agent it is given early in the course of the infection. Moreover, hospitalization can be avoided if treatment starts within the first day of symptoms.

While HCQ alone has been found by numerous studies to reduce mortality rates, severity of symptoms, and length of hospital stays, it also can be combined with zinc and either azithromycin or doxycycline, followed by corticosteroids (prednisone, dexamethasone), and in some cases anticoagulants all working together for improved outcomes. For each one of these drugs, there is both a good scientific rationale and either early clinical trials completed or planned with sufficient promise.

Of these drugs, only HCQ was singled out as a political football early in spring right after President TrumpDonald John TrumpJoe Arpaio loses bid for his old position as sheriff Trump brushes off view that Russia denigrating Biden: 'Nobody's been tougher on Russia than I have' Trump tees up executive orders on economy but won't sign yet MORE urged the medical community to consider HCQ. At the time, one of Trumps top medical advisers, Dr. Anthony FauciAnthony FauciOvernight Health Care: Trump to take executive action after coronavirus talks collapse | Vaccine official says he'd resign if pressured politically Fauci's DC neighbors put up 'thank you' signs in their yards Cuomo says New York schools can reopen in-person this fall MORE, stated that if a COVID-19 patient were under his care, he would use HCQ, preferably in a clinical trial protocol. Fauci, however, has since backed away from that statement and his opposition has become a rallying cry of the left-leaning mainstream medias Hydroxy Hysteria.

The politicization of HCQ is an ongoing tragedy. The Federal Emergency Management Agency (FEMA) has more than 60 million HCQ tablets sitting in its warehouses. Absent a new Emergency Use Authorization, FEMA cannot ship this valuable medicine for appropriate off-label treatment of COVID-19 patients. Nor can hospitals or clinics easily recruit patients for the kind of randomized clinical trials needed to ultimately settle the question of how HCQ might best be used in the fight against COVID-19. Should it be purely in early treatment, as a prophylactic for health care workers or senior home patients at risk, in outpatient versus hospital settings, or in other settings?

Positive HCQ studies have been dismissed in medical journal editorials as flawed because they were observational rather than randomized. The few randomized trials of HCQ reported to date have been a debacle because of the failure to distinguish clearly between early treatment (one to seven days after the onset of symptoms), when the medicine should work, versus later treatment, when it is unlikely to help. To make matters worse, in a classic statistical type two error, many of the preventive and early illness trials of HCQ changed primary endpoints, reduced sample sizes, and became unable to see the benefit of HCQ, if indeed it was there.

For example, the University of Minnesota, in a collaboration with other centers, published randomized prevention and early treatment trials. While both trials were stopped early and thereby had small samples, both made definitive claims that HCQ was not effective. However, careful review of their data shows just the opposite numerically (but not statistically significant) lower numbers of infections and hospitalizations in those who were randomized to HCQ.

Further clouding the issue, the National Institutes of Health opened an outpatient trial of HCQ and azithromycin in May but closed it in June, stating they could not recruit subjects into the study. This was a highly disingenuous claim, given the overwhelming numbers of COVID-19 patients desperate for treatment.

My own conclusion from a review of the literature is that HCQ has not failed the randomized trials, but researchers have failed HCQ. Many doctors who understand the science and the threats to validity in the HCQ literature continue to prescribe HCQ appropriately off-label to COVID-19 victims at home, in senior centers, and early in the hospital. The Association of American Physicians and Surgeons is suing the FDA for access to HCQ.

In thinking carefully about all the negative news that you may have heard about HCQ, keep in mind this drug has been used in the U.S. since 1955. It has a completely established safety record for lupus, rheumatoid arthritis, and malaria prevention and treatment. Prescribed under a physicians good judgment, it is unlikely to cause harm.

So how did HCQ become considered dangerous? The first false safety concerns arose early in the pandemic in reports that doctors prescribed HCQ not in an early treatment setting at the first sign of symptoms but rather in a late-stage setting to more severely ill patients in the hospital. This form of treatment bias that is, giving medicine to the sickest before death created a false association between HCQ and mortality. Unfortunately, the mainstream media picked up on these reports and did great damage by promulgating a false narrative without understanding the epidemiological underpinning of confounding by indication.

In what would be a death blow to public trust of HCQ, the prestigious Lancet journal published a massive worldwide study that purported to show excessive deaths in patients treated across six continents only to have the paper later retracted. The New England Journal of Medicine had a similar unprecedented retraction more evidence of HCQ becoming a political football in medical science. While the studies were fraudulent and discredited within a few weeks, the media coverage, and earlier flawed studies, led both the FDA and World Health Organization (WHO) to withdraw endorsements of the drug for COVID-19 treatment.

We now know, based on thelarge New York and Detroit experiences at Ford and Mt. Sinai hospitals, that HCQ is safe. To date, there has not been a single credible report that the medication increases the risk of death in COVID-19 patients when prescribed by competent physicians who understand its safety profile.

It is time for the FDA and state medical boards to support the use of HCQ in conjunction with other commonly used drugs steroids and antithrombotics against COVID-19, treated early at home to help avoid hospitalization and death. As President Trump has said, what have you got to lose by reinstating an Emergency Use Authorization? As to what might be gained, appropriate research and prescription (combined with other medications) could spare hundreds of thousands of hospitalizations and save tens of thousands of American lives.

Peter A. McCullough, MD, MPH, is vice chairman of medicine at Baylor University Medical Center and a professor of medicine at Texas A&M College of Medicine in Dallas. An internist, cardiologist and epidemiologist, he is the editor in chief of Cardiorenal Medicine and Reviews in Cardiovascular Medicine. He has authored over 500 cited works in the National Library of Medicine.

Read the original post:

Why doctors and researchers need access to hydroxychloroquine | TheHill - The Hill

Notable Launches New Clinical Study With Washington University School of Medicine Exploring Ex Vivo Drug Screening to Predict Chemotherapy Sensitivity…

FOSTER CITY, Calif.--(BUSINESS WIRE)--Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced a new precision oncology study with Washington University School of Medicine in St. Louis, exploring the feasibility of ex vivo drug screening to predict sensitivity and resistance to chemotherapy, and to identify novel synergies across a broad panel of anticancer therapies.

The study will help determine to what extent Notable's technology platform has the ability to predict clinical responses in patients treated with standard of care therapies in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). In addition, the study explores how a patient's disease changes in response to specific therapies, and whether Notable can potentially combat resistance to therapy by finding new effective combinations on its platform.

The study will be conducted at Washington University School of Medicines Siteman Cancer Center. Notable is performing the ex vivo drug sensitivity tests in its laboratory in Foster City.

This is a very important validation study for Notable, said Hiroomi Tada, M.D., Ph.D., chief medical officer at Notable. It will provide a large dataset that will enable us to compare our ex vivo test results with patient outcomes, which we need to understand how well our assays work, and determine whether we need to improve the assays for certain classes of drugs to make the tests better. In addition, the study will provide us with insight into how AML and MDS change in response to treatment, identify potential new combination therapies and if patients are failing a therapy much earlier, allowing us to intervene sooner as resistance is emerging.

Medical oncologist John Welch, M.D., Ph.D., associate professor in the division of oncology at Washington University School of Medicine, said, It can be difficult to predict patients responses to chemotherapy, and we look forward to evaluating whether Notables platform has the potential to change the way clinicians approach cancer therapy for individual patients. This trial is intended to help determine the platforms accuracy and its value as a clinical care tool.

This is expected be a five-year study, though data from the first cohort could be available within 1218 months.

About Notable

Notable is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers. Notables testing platform combines machine learning, automation and high-throughput screening directly on patient samples to predict responses to potential therapies, and ultimately determine which therapies will be most effective for specific cancers. Notables functional precision medicine platform will advance drug development and enable pharmaceutical companies to get new therapies to patients faster. Learn more at notablelabs.com and follow us @notablelabs.

Go here to see the original:

Notable Launches New Clinical Study With Washington University School of Medicine Exploring Ex Vivo Drug Screening to Predict Chemotherapy Sensitivity...

Not Everyone Needs 8 Hours of Sleep, New Research Reveals – TIME

For as long as Seemay Chou can remember, she has gone to bed at midnight and woken around 4:30 a.m. Chou long assumed that meant she was a bad sleeper. Not that she felt bad. In fact, sleeping just four hours a night left her feeling full of energy and with free time to get more done at her job leading a research lab that studies bacteria. It feels really good for me to sleep four hours, she says. When Im in that rhythm, thats when I feel my best.

Still, in an effort to match the slumber schedules of the rest of the world, she would sometimes drug herselfwith melatonin, alcohol or marijuana ediblesinto getting more sleep. It backfired. If I sleep seven or eight hours, I feel way worse, she says. Hung over, almost.

Although the federal government recommends that Americans sleep seven or more hours per night for optimal health and functioning, new research is challenging the assumption that sleep is a one-size-fits-all phenomenon. Scientists have found that our internal body clocks vary so greatly that they could form the next frontiers of personalized medicine. By listening more closely to the ticking of our internal clocks, researchers expect to uncover novel ways to help everybody get more out of their sleeping and waking lives.

Human sleep is largely a mystery. We know its important; getting too little is linked to heightened risk for metabolic disorders, Type 2 diabetes, psychiatric disorders, autoimmune disease, neurodegeneration and many types of cancer. Its probably true that bad sleep leads to increased risks of virtually every disorder, says Dr. Louis Ptacek, a neurology professor at the University of California, San Francisco (UCSF). But details about whats actually going on during shut-eye are sparse. We know almost nothing about sleep and how its regulated, says Ptacek.

Some people are morning larks, rising early, and others are night owls, who like staying up late. Those patterns are regulated by the bodys circadian rhythm, a 24-hour internal clock. People can manipulate their circadian rhythm through all kinds of external factors, like setting an alarm clock or exposing themselves to light. But the ideal sleep duration has long been thought to be universal. There are many people who think everyone needs eight to eight and a half hours of sleep per night and there will be health consequences if they dont get it, says Ptacek. But thats as crazy as saying everybody has to be 5 ft. 10 in. tall. Its just not true.

Ptacek and his wife Ying-Hui Fu, also a professor of neurology at UCSF, are pioneers in the relatively new field of sleep genetics. About a decade ago, Fu discovered the first human gene linked to natural short sleep; people who had a rare genetic mutation seemed to get the same benefits from six hours of sleep a night as those without the mutation got from eight hours. In 2019, Fu and Ptacek discovered two more genes connected to natural short sleep, and theyll soon submit a paper describing a fourth, providing even more evidence that functioning well on less sleep is a genetic trait.

The researchers are now collecting data on short sleepers in order to figure out just how rare these mutations are. If we can get a better understanding of why their sleep is more efficient, we can then come back and help everybody sleep more efficiently, Fu says. Among the participants is Chou, who also happens to work at UCSF. One day at a faculty meeting, she and Ptacek chatted about his work. She immediately recognized herself when he described short sleepers. I had never heard of this. But once I started reading about it, it was sort of an epiphany.

Chou doesnt know yet if she has the identified genetic variants. But after the researchers interviewed her about her familys sleeping patterns, she realized her mom is also a short sleeper. I have memories of when I was younger, and my dad being frustrated with her for staying up really late, but she always seemed fine, she says. The researchers took blood samples from both women.

Doctors once dismissed short sleepers like Chou as depressed or suffering from insomnia. Yet short sleepers may actually have an edge over everyone else. Research is still early, but Fu has found that besides being more efficient at sleep, they tend to be more energetic and optimistic and have a higher tolerance for pain than people who need to spend more time in bed. They also tend to live longer. Chou says the first three hold true for her; by nature, she is sunny and positive, and though she often finds bruises on her body, she usually doesnt remember getting them. I find it annoying how much people complain about little physical pains, she says.

So far, these are just intriguing observations. But by studying genetic short sleepers, Fu and Ptacek believe theyll eventually learn lessons for the rest of us. As we identify more and more genes and we think about the pathways in which they function, at some point, a picture is going to emerge, and we will begin to have an understanding of how sleep is regulated in greater detail, Ptacek says. This, they hope, will lead to targeted treatments, like pills or vitamins, to improve sleep efficiency in everyone.

Researchers are also looking beyond sleep to other circadian bodily processes that might benefit from a personalized or targeted approach. While a master clock in the brain acts like a conductor, setting time for the whole body, the rest of the body is like orchestra players with clocks of their own. All your organs have rhythms, says Steven Lockley, an associate professor of medicine at Harvard Medical School who studies circadian rhythms and sleep. Theres a clock in your heart, a clock in the lungs, a clock in the kidneys. Just about everything in the bodymetabolism, hormones, the immune system, reproductive function and the way DNA is translatedis influenced by a circadian rhythm, he says.

And not everybodys is the same. Peoples internal clocks are often hours off from one another, Lockley says. The range of individual differences is much bigger than anyone really understands yet.

The bodys complex clock system has implications for both healthy people and those with medical conditions, and scientists are already seeing glimpses of how they can time certain tests and treatments to get more accurate or potent results. A cholesterol reading, for example, might be affected by what time of day you go to the doctors office, because the liver (which makes cholesterol) has a circadian rhythm. The time of day at which you measure something could make someone look clinically abnormal, even though theyre not, Lockley says.

Medicine might also be more effective if taken at a certain time. Because theyre metabolized in the liver, drugs change their effects throughout the day, Lockley says. Other circadian bodily processes, like cell function, can also affect how medication acts. Early research suggests certain drugsincluding some for colorectal cancer, pain and asthmaperform better or are less toxic when taken at different times of day.

Exercise, which can be as powerful as medicine for some conditions, is good for you whenever you do it. But I do think that the time of day may have an influence, on top of the effects of exercise, on our metabolic health, says Juleen Zierath, professor of physiology at Karolinska Institute in Sweden. In one small study published in 2018 in the journal Diabetologia, Zierath and her team started 11 men with Type 2 diabetes on a high-intensity interval training program. The men exercised either in the morning (around 8 a.m.) or the afternoon (4 p.m.) for two weeks, then switched schedules. The researchers expected that regardless of the time of day, men in both groups would see improvements in blood-sugar levels. But when they exercised in the morning, they actually had slightly higher levels of blood sugar [than baseline], which we didnt expect at all, Zierath says. Its not clear to what extent the type of exercise and other variables matter, but the study provides an intriguing hint that time of day might make a difference for exercise.

Scientific knowledge is nascent when it comes to optimizing testing and treatment by the clock. Our understanding of individual circadian time is even more primitive. But Lockley believes its the key to personalized medicine; he and others are exploring ways to measure a persons internal circadian time through simple clinical tests. Hopefully in the next five to 10 years, youd go to the doctor, give a breath test or a pee sample, and the doctor would know your biological time, he says. Then all your test results and treatments could be based on your real internal time, which is going to be very different between you and me based on our internal clocks.

For now, even the understanding that our bodies often operate according to different clocks is a big scientific advance. Its already changed the way Chou sleeps, lives and works. Ive just become more comfortable with accepting my sleep, she says. She now asks her employees about their sleep schedules to anticipate when each will be at their peak. She also informs everyone about her own abbreviated schedule, so they know she doesnt expect an immediate response to an email she sends at 4:05 a.m. Thats just when my brain is working, she says.

This appears in the August 17, 2020 issue of TIME.

For your security, we've sent a confirmation email to the address you entered. Click the link to confirm your subscription and begin receiving our newsletters. If you don't get the confirmation within 10 minutes, please check your spam folder.

Write to Mandy Oaklander at mandy.oaklander@time.com.

Read the original here:

Not Everyone Needs 8 Hours of Sleep, New Research Reveals - TIME

Letters: Zoom medicine could never beat the stethoscope – HeraldScotland

I COULD not agree more with the sentiments of Dr Hamish Maclaren (Letters, August 4) when he cautioned against Zoom medicine being accepted as the new norm. While at medical school in Glasgow I benefited very much from the teachings of Macleods Clinical Examination and learned that in sitting talking with a patient, checking the rate, rhythm and volume of their pulse while examining the eyes for any sign of anaemia or jaundice can be very helpful signs as to how well or otherwise that person might be.

While video consultations are able to give us some of the clinical picture, I have not yet mastered the art of ascertaining as to whether there are any crackles or wheezes in the chest by way of Zoom rather than by my use of the stethoscope.

Dr Alan Mitchell, Motherwell.

I SHARE the serious concerns expressed by Dr Hamish Maclaren on the subject of "Zoom medicine". The views of a politician temporarily in the post of Health Secretary for England should not be allowed to lead to such a radical change in the nature of the centuries-old traditional relationship between doctor and patient.

Further, I would invite doctors to consider how readily such a definitive change, other than in exceptional circumstances can be equated with part of the Hippocratic Oath, which in a modern version states inter alia: "I will remember that there is art to medicine as well as science, and that warmth, sympathy and understanding may outweigh the surgeon's knife or the chemist's drugs." It is difficult to imagine Zoom medicine generating comparable amounts of those three highly desirable and beneficial elements of the human condition.

Ian W Thomson, Lenzie.

CAN I voice my complete agreement with David Bryson (Letters, August 4) in his comments regarding opening pubs but not gyms?

Sadly this reflects politicians' inability to see beyond short-term problems: the health of the nation has a massive impact on our health services, but that is in the future so why not let someone else sort it out later? Physical health has been shown time and again to improve our medical needs as we age, even to the extent of shortening recovery times post-operations.

So why are pubs opening when only a fantasist would believe that after several drinks customers will adhere to social distancing guidelines? In our tennis and fitness centre in Prestwick we have utilised one of our indoor courts to space out gym machines and exercise classes, so everyone adheres to social distancing and our members' judgment will not be impaired by alcohol. Yet we cannot open. I appreciate there are problems with large gyms, especially those which are unsupervised, but gyms like ours which are constantly supervised by qualified instructors must represent a far lesser risk than certain pub chains.

Until our politicians are willing to face up to the massive hidden costs of obesity and poor physical fitness they will continue to burden the NHS with unnecessary costs.

David Stubley, Prestwick.

I AM sure Nicola Sturgeon is very aware of the obesity crisis, however you do not have to visit a gym to lose weight and stay healthy.

I make sure I have a good healthy diet and I take plenty of (free) exercise by walking, working in my garden, keeping myself busy around the house and not sitting about eating junk food.

I am a fit and healthy 81-year-old and have never visited a gym in my life.

Ellen Japp, High Blantyre.

Continue reading here:

Letters: Zoom medicine could never beat the stethoscope - HeraldScotland

Children, teens, and the safety of psychotropic medicines – Harvard Health Blog – Harvard Health

Medicines prescribed for attention deficit/hyperactivity disorder (ADHD), depression, anxiety, and other mood disorders known as psychotropic drugs have largely been studied in adults. This concerns many parents whose children take these drugs regularly. Studies have most often looked at the effectiveness of these medicines in teens and children. Now a recent systematic review of multiple studies done in children and adolescents offers new guidance on safety for commonly used medicines.

The aim of this study was to comprehensively synthesize current evidence on the safety of four major classes of psychotropic drugs given to children and adolescents. This helps clinicians make decisions when prescribing, and assists in developing well-grounded guidelines. It also helps identify areas needing further research.

The researchers focused on adverse events, such as side effects or other problems, linked to 80 medicines in four categories: antidepressants, antipsychotics, anti-ADHD medications, and mood stabilizers. Altogether, the studies considered data from 337,686 children and teens. Most study participants were taking either anti-ADHD medicines or antidepressants (roughly 149,000 and 121,000, respectively). Smaller numbers took antipsychotics or mood stabilizers (roughly 67,000 and 1,600).

The study looked at safety profiles and common side effects, which were available in the scientific literature for some, but not all of the medicines: 18 antidepressant medicines; 15 antipsychotic medicines; seven anti-ADHD medicines; and six mood stabilizers. While side effects were modest overall, the researchers found the following:

The authors acknowledge that there were limited data about adverse events for many of these medications. Therefore, a more comprehensive reporting of adverse events is necessary in future research on the use of psychotropic medications in children and adolescents. Additionally, long-term and rare side effects are likely underrepresented here, due to the limited availability of longer-term data.

While medication is one of the stronger treatment tools in mental health care, its not the only one. Especially for children and teens, it is essential to approach behaviors holistically by considering biology, psychology, and social and environmental factors. Frequently, medication is combined with other approaches, such as individual therapy, family therapy, and multidisciplinary, system-based approaches like developing an IEP (individualized education program) for school. A comprehensive assessment can guide the care team in making appropriate plans aimed at an optimal outcome.

See more here:

Children, teens, and the safety of psychotropic medicines - Harvard Health Blog - Harvard Health

Partnership produces business innovation grant to be offered as marketing boost – Medicine Hat News

By Medicine Hat News on August 6, 2020.

A business innovation grant in Medicine Hat will now include up to $1,500 for the use of a professional photographer and marketing specialist.

Grant recipients must be registered for ShopHERE powered by Google.

On July 13 APEX Alberta, Medicine Hat and District Chamber of Commerce and Invest Medicine Hat announced their collaboration with the ShopHERE powered by Google program. The goal is to get 250 businesses online this year providing businesses and artists an opportunity to build a digital presence and minimize the economic impact of the COVID-19 pandemic without any additional costs.

Our businesses must be able to expand their businesses online in order to remain competitive in todays world, said Mayor Ted Clugston. We are now able to offer our businesses the support to build an e-commerce website for free and up to $1,500 to create a professional website with local photography and marketing services. We are looking to keep the grant dollars local wherever possible.

A registered business for the program is eligible to receive up to $1,000 that can be used to hire a local Medicine Hat photographer to feature products displayed on the e-commerce website. They may also be eligible for up to $500 for the use of a local marketing firm to guide the photo shoot and provide a promotional strategy for the newly designed e-commerce website.

You can register your business at http://apexalberta.ca/shophere

To apply for the CMHBIG for ShopHERE users, visit the Community Futures Entre-Corp website at:

http://entre-corp.albertacf.com/mhbig

You must be logged in to post a comment.

Here is the original post:

Partnership produces business innovation grant to be offered as marketing boost - Medicine Hat News

Sharing information with public is important medicine in COVID-19 fight – Modern Healthcare

Hearing a need among community members for clear information about best practices to mitigate risks of COVID-19, University Hospitals in early May launched a toolkit to help businesses navigate returning to work.

First the system heard from leaders of essential services, then more and more businesses and community members asked for help understanding safety practices: masking, distancing, cleaning protocols and more. As the requests grew, UH wanted to get information to a broader audience than just those who had reached out.

"I think we quickly realized that this needed to be content that stood up so it was available to everyone in the community, not just the people we were able to work with one-on-one," said Dr. Joan Zoltanski, UH's chief experience officer who has been leading the system's Healthy Restart efforts.

In the past three months, the UH Healthy Restart Playbooks free online, up-to-date resources for employers and schools have been downloaded thousands of times.

Cleveland Clinic was hearing similar requests for information from the community and launched its own support system for businesses shortly after UH. The Clinic's AtWork program offers COVID-19 response resources, including webinars, industry-specific guides and a hotline for advice.

"The top three things that people are asking of us that we're working for and working with is interpretation, clarification and translation," said Dr. James Merlino, the Clinic's chief clinical transformation officer.

Though the health systems may have offered advice here and there, consulting at this scale is new for them. The science behind mitigating risk of spreading disease, of course, is not. Hospitals have been masking and cleaning for infectious disease and viruses long before COVID-19. Pivoting the expertise that they implement in their own facilities to community education made sense, Zoltanski said.

In the absence of a vaccine or antiviral medication, the Cuyahoga County Board of Health is working with five tenants of non-pharmaceutical interventions, said Kevin Brennan, communications officer for the board. These are handwashing, social distancing, mask wearing, cleaning and disinfecting of commonly touched surfaces and health screenings.

Because health systems and the board of health can reach different audiences, hospitals amplifying the messaging about such practices is helpful, he said. While the health systems have been able to provide some level of proactive, individualized guidance to businesses, the board's business response is complaint-driven education.

"I think we can't be everywhere we want to be; we can't be everything to everyone," Brennan said. "So we're glad that an authority such as a hospital would be willing to step up and fill that void. We feel like there's reliability in the fact that they have expertise given the composition of their staff members and their history, so I think we're pleased to see that."

Summa Health has proactively reached out to local businesses to offer resources, such as webinars and Q&A sessions. MetroHealth has worked on protocols with Cleveland Public Library, Destination Cleveland and area schools, but the system isn't making direct consulting with businesses a big part of their response. Rather, its work as an essential hospital has been more in health equity and access during this pandemic, like ensuring essential workers get tested and know how to protect themselves, said Dr. Brook Watts, MetroHealth's vice president and chief quality officer.

The Clinic is working with nearly 150 entities around the world to help them think about and implement best practices. Some of these have taken the form of a more public relationship. For instance, Clorox Co. and the Clinic announced in mid-July a partnership they would collaborate to develop a free online guide for employers to help them train personnel, select effective products and develop robust cleaning and disinfection processes.

Some of the Clinic's partnerships support individual businesses, while others help push information to the public more broadly, such as working with Jones Day to help with webinars for clients or collaborating with the Adventure Travel Trade Association a network of travel agencies around the world to develop free guidelines for travelers.

UH, whose outreach focuses on Northeast Ohio, has also worked with convener organizations, like chambers of commerce or groups of mayors, to give them more information, answer specific questions and help them best communicate that.

Although the Clinic doesn't yet have an answer, it's starting to look at what the free services and these new relationships might mean in the future. But for now, the focus is on the reality communities and businesses are facing for at least the near future: living with COVID-19.

UH's playbooks and all data published online are available for free. When businesses are looking for a deep dive or would like an expert to review their back-to-work plans with an infectious disease doctor or specialist, UH has charged a bit to cover costs. The system doesn't see it as a money-making operation but a mission-driven effort to slow the spread, Zoltanski said.

"Our infectious disease, our clinicians were very motivated to get behind this," she said. "As you can fully well imagine, they couldn't possibly be busier than they are right now, but when I said to them, 'Hey, we want to help businesses,' they showed up on Saturday mornings to work through content in the little time off they had because we said we want to help the community, and that was really the why of this for us."

The Clinic's "powerful brand" around the world is part of why organizations have reached out, Merlino said.

Leveraging that brand could help to combat some of the misinformation, and in some ways mistrust, among members of the public. Merlino said the Clinic is working alongside UH and MetroHealth on how to educate and reinforce the message.

"We're starting to have these conversations. We need to be able to do more, to really conquer that," he said.

Though some parts of pandemic response are political, Zoltanski said UH sticks to the medicine, the science and the trusted partnership it has developed with the community. Beyond sharing the best medically sound advice, it's important to also be transparent, honest and admit what remains unknown, she said.

Merlino recognizes that there may always be people who don't accept or follow the basic guidelines agreed upon by the scientific and medical communities, but it's important to continue reinforcing their importance.

"Sharing information with public is important medicine in COVID-19 fight" originally appeared in Crain's Cleveland Business.

Originally posted here:

Sharing information with public is important medicine in COVID-19 fight - Modern Healthcare

MoceanLab and USC Keck School of Medicine Launch Program to Help USC’s Street Medicine Team Deliver Care to L.A.’s Homeless Residents – Business Wire

LOS ANGELES--(BUSINESS WIRE)--MoceanLab, a new L.A.-based mobility laboratory developed by Hyundai Motor Group, is launching a program to help the USC Keck School of Medicines Street Medicine Team care for some of the citys most vulnerable and hard to reach residents: L.A.s unsheltered homeless population.

MoceanLab is providing low-emission hybrid vehicles from its growing Mocean Carshare service to be used by the renowned Street Medicine Team as they travel to serve homeless residents where they reside: in homeless encampments, under freeway overpasses and in other areas that seem a world away from conventional treatment settings. The effort is part of the companys commitment to create innovative mobility solutions that benefit residents, neighborhoods and communities throughout Los Angeles, including those most in need.

All of us at MoceanLab are inspired by the selfless, heroic work of USCs Street Medicine Team in caring for a population that faces unique challenges and is too often left behind, said MoceanLab Vice President Dave Gallon. Through collaborations with top-quality institutions like USC and others, we can deliver on our mission of improving the quality of life for Angelenos of all backgrounds.

Embracing a philosophy of radical humility, the USC Keck Schools Street Medicine Team provides a full spectrum of services to homeless Angelenos, all at no cost. They include treatment for chronic conditions such as high blood pressure and diabetes, dispensing medications, obtaining blood work, delivering drug and alcohol counseling and basic mental health services, and providing basic survival supplies.

USCs team also informs the academic work of researchers seeking to better understand the challenges facing the unsheltered homeless population, develop more effective care, and help address the root causes of homelessness.

L.A.s large unhoused population faces a disproportionate burden of chronic and acute health challenges, particularly during the coronavirus outbreak, but often have few options for high-quality and compassionate care, said Brett Feldman, USCs Director of Street Medicine and Vice Chair of the Street Medicine Institute. Our motto on the Street Medicine Team is, Go to the people. Our collaboration with Mocean Carshare will help us improve the physical, mental and emotional wellbeing of these vulnerable men and women directly in the environments where they are most comfortable.

MoceanLab was launched uniquely for Los Angeles one of the worlds most dynamic, diverse and transportation-challenged cities to develop equitable, environmentally sustainable new ways to move around safely and efficiently. As a laboratory for innovation, MoceanLab embraces a wide range of partners and collaborators to create forward-leaning mobility solutions. MoceanLab is backed by the global resources and expertise of its parent, the Hyundai Motor Group.

MoceanLabs first initiative, Mocean Carshare is a convenient car sharing service launched earlier this year that allows drivers to quickly and easily rent a low-emission hybrid electric car and return it anywhere in Downtown L.A.

Addressing the challenge of chronic homelessness is an urgent priority in communities throughout Los Angeles, especially as the COVID-19 pandemic and resulting economic slowdown place new burdens on families and individuals, said Aaron Gross, L.A.s Chief Resilience Officer. This collaboration with MoceanLab will expand the transformative power of USCs Street Medicine Team and have a profound impact on residents in need who deserve this excellent, humane medical care.

More here:

MoceanLab and USC Keck School of Medicine Launch Program to Help USC's Street Medicine Team Deliver Care to L.A.'s Homeless Residents - Business Wire

Miner, man of medicine and Ohio University grad, played research role in 1918 epidemic – Athens NEWS

Editors Note: This is the first installment of a two-part series detailing the Spanish Influenza and its ties to Athens County and Ohio. This first installment highlights the life and efforts of a man who lived in Athens for a time and had an unexpected role in the Influenza Pandemic of 1918. The next installment, to be printed in a future edition, will detail the responses Athens County had to the influenza pandemic in 1918 and 1919, as well as the responses of other leaders in the state during the time.

An Ohio University graduate of yesteryear played a role in identifying the aggressive virus that may have triggered the Influenza Pandemic of 1918.

Dr. Loring Miner is credited by many health officials and historians as the discoverer of the 1918 flu epidemic, more popularly known as the Spanish Flu.

The physician was practicing medicine in Haskell County, located west of Dodge City in Kansas. The Ohio University graduate began his practice in the Kansas county in 1885.

Haskell County was a far cry from his previous home of Athens, Ohio. His practice expanded hundreds of miles over the frontier. Miner seemed to have enjoyed the change in scenery, however, and became rather embedded in the community.

According to author John M. Barry, who wrote about Dr. Miner in his book The Great Influenza, Miner served as the countys coroner for a time, as well as county health officer and as a chair in the countys chapter of the Democratic Party.

Aside from that, he also was a businessman, owning a grocery store and a drug store, both of which he fully expected his patients to frequent.

Miner was described by author John M. Barry as being a large, gruff man with an affinity for alcohol, but a skilled physician nonetheless.

Miner witnessed an unforgiving virus overtaking young men in his area, with symptoms that included a severe headache, a high fever and a non-productive cough, with the first patient of this kind appearing in January of 1918. According to Barry, Miner ultimately diagnosed the virus as influenza, but the doctor soon noticed the virus was progressing rapidly, and patients who normally would have a speedy recovery healthy young men were dying. He saw cases of this severe flu pop up in different parts of Haskell County.

Miner was thorough in his approach to gaining an understanding of the aggressive virus he had witnessed in many of his patients, Barry wrote. He conducted lab studies, searched through medical journals and had consultations with colleagues to gain clarity. He also utilized available vaccines, such as the tetanus shot, in hopes of stimulating the immune system of infected people.

This time of intense research was tough on the doctor. Barry found in an interview published in a Kansas magazine that Dr. Miner often slept on his way home from his doctor visits for the day while his trusty horse pulled him along the quiet Kansas roads.

Miner ultimately was the first person to report this aggressive virus, thought to be an early strain of the Spanish Flu, to the U.S. Public Health Service.

No other reports were submitted to the U.S. Public Health Service in regards to this influenza of a severe type, as Miner described it, for another six months.

At the time, influenza was not considered a reportable disease, nor was it a disease that health officials tracked, Barry wrote. Diseases that were often reported to the U.S. Public Health Service included polio, diphtheria, measles, mumps, scarlet fever and smallpox.

Kansas was also home to Camp Funston at Fort Riley, which housed roughly 56,000 troops at that time.

Nearly 500 soldiers were hospitalized in the span of a week as they started falling ill with symptoms identical to what Miner had seen earlier that year. The troops from this camp were later mobilized to Europe during WWI, where they likely brought the disease with them. In theory, troops who came home likely brought the virus back to the States, this time stronger and mutated, Barry wrote.

Miners former home of Athens County also saw deaths linked to the Spanish Flu. Oddly enough, an outbreak at a nearby military camp also was the root of many cases of the virus in Athens County.

Ohio History Connection curator Karen Robertson found in her recent research of Ohios various responses to the Spanish Flu that Ross County became a hotspot for the virus.

More than 1,000 men died at Camp Sherman before the epidemic ended in 1919, according to Ohio History Connection.

Ohios historical society also noted that Camp Sherman was affected more by the epidemic than any other training camp in the nation.

Robertson noted that nearly 6,000 troops at Camp Sherman, however, fell ill with the Spanish Flu. Super flu symptoms popped up in the camp beginning that summer, progressing rapidly into the fall of 1918.

As the death count rose locally, the nearby Majestic Theatre in Chillicothe was used as a temporary morgue, Robertson found. Nurses were reportedly stacking bodies on top of one another like cordwood, and the fluids from the corpses flowed into a neighboring alleyway. This alley is still referred to as Blood Alley, Robertson said.

In Athens County specifically, several families with relatives who were at Camp Sherman became infected with the Spanish Flu.

One Congress Run household was infected after the familys son returned from Camp Sherman on furlough but developed the disease as soon as he arrived at home and his condition was serious for several days, but was in recovery, according to the Oct. 8, 1918 edition of The Athens Messenger.

Other more isolated cases in the county were also reported in the Glouster area, in Bishopville and in Mountville, according to several editions of The Athens Messenger. The Messenger provided daily updates in regards to area residents falling ill to the Spanish Flu, recovering or dying.

In nearby Hocking County, a Murray City woman died of complications that resulted from the Spanish Flu. She had been at Camp Sherman weeks prior to her passing, and reportedly fell ill shortly after returning from the military camp in Ross County.

View original post here:

Miner, man of medicine and Ohio University grad, played research role in 1918 epidemic - Athens NEWS

‘Shift’ into healing through yoga and holistic medicine – Yes! Weekly

A Winston-Salem yoga studio and a holistic health coach-in-training are teaming up to help their community heal through a weeklong virtual retreat at the end of this month.

Kris Neville, 20, is a yoga instructor, a holistic health coach-in-training, and the youngest son of John Neville, who died in December 2019 after being under the supervision of five former Forsyth County Detention Center officers and one nurse.

After learning of his fathers avoidable death, as characterized by District Attorney Jim ONeill, Neville and the rest of his family were left to pick up the pieces and silently struggle with grief. He said for the past three weeks, the #OccupyWSNC movement in Bailey Park demanding transparency and policy change from his fathers death has made him feel empowered, and it has inspired him to help others heal through the tools that helped him.

It really does suck, but I refuse to let that bring me down and tear me back from my own successonce I start to believe the reality that my fathers death is a reason for me to be depressed, sad, and have regrets, and have fears about anything that might happen in my life, it will immediately turn off any future of prosperity for me, he said. I refuse to be a failureI will be successful, I will fight for justice and make a change alongside the change I am trying to make in the health and wellness community.

Neville and Chlo Craver, 29, owner of Lotus Yoga Academy, are the hosts for the Shift Virtual Wellness Retreat, taking place from Aug. 23-30.

Ive had to switch everything for Lotus Yoga to an online platform because we are still closed, as we are technically a gym, Craver said. I think now we have a pretty good system fluidity in how to offer virtual things, so its been seamless.

Craver started doing yoga about 10-12 years ago because she felt disconnected from her body, which was causing her to struggle physically, emotionally and spiritually. About a year and a half ago, she opened Lotus originally as a yoga teacher-training program, but it eventually blossomed into a yoga studio. Neville started attending Lotus regularly in August 2019, and he got his yoga instructor certification this past February. He described yoga as something that was life-changing for him.

It is the decision that probably helped to heal so much of me, Neville said. My yoga teacher training healed so many parts of me just through January through March, because during that time, I was silently dealing with the death of my father. I was able to really reconcile and learn how to cope.

Neville is studying at the Institute for Integrative Nutrition to be a holistic health consultant, and he said he would be fully certified by September. Once he is certified, hell officially launch his business, Wellness Rising Health, which through the use of plant medicine, yoga, mantra, and meditation, would help connect people to the earth and to each other.

Both Craver and Neville have used yoga to help heal their trauma, and the two became good friends after Neville started practicing at Lotus. With Cravers knowledge of yoga and meditation coupled with Nevilles knowledge of holistic medicine and nutrition, the Shift Virtual Wellness Retreat blends their expertise into a program composed of daily hour-long video content with follow-up Zoom call sessions each evening for attendees to reflect, share and ask questions.

The theme of the whole week is Shift, Craver said. Shift means, to us, the process of slowing down, of healing, integrating, focusing and transforming.

Coming out of summer, it is a time of intense heat and growth, and going into the fall its time to prepare for harvesting the intentions, manifestations and reaping what you sowed at the end of the season, Neville said. I think we can help prepare people to shift into a new mindset to understand the value of their words, manifestations and thoughts to create the reality they want.

Craver and Neville have curated yoga practices, meditations, and oils that correspond to each topic over the course of five days. That weekend, they will tie in what was learned the past week, and attendees will make a commitment to themselves based on what they experienced.

You cant rely on anyone to do your inner work for you or to do your healing for you, but it helps to have a little nudge, especially from people who have experienced it and done it for themselves, Craver said. We are giving people the tools to take back their own health and take back their own power, especially in a time that feels so disempowering.

Additionally, 20% of the proceeds from the Shift Virtual Wellness Retreat will go directly to support the Triad Abolition Project, the organization spearheading the #OccupyWSNC movement.

Neville said donating to the Triad Abolition Project is special to him because he believes in practicing civil disobedience to make meaningful change. Anything we can do to help these people get back out there on the street and create that scene of uncomfortability for the people who need to make the change, I will do what I can for that, he said. Once these policy changes are made, it wont be the end of the workit will be the next step to an even better community in Winston-Salem.

To get people curious about the virtual retreat, Craver and Neville are hosting two donation-based yoga and essential oil classes on the Lotus Yoga Academy patio, Aug. 8 and Aug. 22 at 6 p.m. These classes are 45-minutes of slow-flow yoga accompanied by some of the essential oils used during the retreat, followed by a 20-minute discussion led by Neville on how the oils work.

Craver said no experience with yoga or essential oils is necessary to attend the retreat, and the only requirement is a willingness to learn.

The price for the entire retreat is $100, with $20 going directly to the Triad Abolition Project. Those who wish to attend need to register by Aug. 19 to receive the introduction package. In an effort to be more inclusive, Craver and Neville are seeking sponsors to help people in economic hardship to participate, and they hope to have at least 10 scholarship spots. Craver said those who sign up for the retreat would also get access to Lotuss patio classes.

I feel, weirdly with everything going on, this fire to make a change, Neville said. Ive done this work internally and its time to do it externallyto make people uncomfortable, and help other people heal.

Original post:

'Shift' into healing through yoga and holistic medicine - Yes! Weekly

Gift to School of Medicine aims to alleviate inland Southern California’s physician shortage – UC Riverside

The School of Medicine at the University of California, Riverside, has received a gift of about $2.6 million from the Inland Empire Health Plan, or IEHP, to provide Mission Awards for the schools students.

The gift to the schools Mission Award program will support up to 23 medical students with tuition and fees who will go on to practice in inland Southern California upon their graduation. The medically underserved region faces a critical shortage in both primary care and specialist physicians with only 35 primary care physicians per 100,000 people far short of the 60 to 80 per 100,000 recommended by the California Health Care Foundation.

Recipients of the four-year awards will need to commit to returning to Riverside, San Bernardino, or Imperial counties after completing their residencies to provide clinical care for at least five consecutive years; recipients of the two-year awards will need to commit to returning to one of these counties after completing their residencies to provide clinical care for at least 30 consecutive months.

Inland Empire Health Plan is a terrific partner to the UCR School of Medicine, and our organizations are aligned in our missions to improve access to health care in the Inland Empire, said Dr. Deborah Deas, vice chancellor for health sciences and Mark and Pam Rubin Dean of the School of Medicine. We are so grateful for this incredibly generous investment in our future physician workforce. The impact of this gift is tremendous because it will increase the number of physicians in the Inland Empire and improve the health care for a largely underserved population.

Students in good academic standing in the medical school are eligible for the Mission Awards, which are either for all four years of medical school or for two years, covering the third and fourth years. Each award covers 100% of tuition and fees. Currently, the first two years of medical school education at UC Riverside cost about $43,000 per year; the third and fourth years cost about $47,000 per year. Summer sessions in the third and fourth years incur additional costs.

UCR School of Medicines mission and commitment to serve and support Inland Empire communities is no secret, said IEHP Chief Executive Officer Jarrod McNaughton. We see this commitment in the framework of their programs and in the hearts of their students. It is our hope that these awards encourage local students to consider careers in medicine and further incentivize qualified students to remain and serve in the Inland Empire.

All Mission Award recipients must also agree to practice in one of the following specialties: emergency medicine, pediatrics, family medicine, general internal medicine, OB/GYN, general surgery, or psychiatry. Should an award recipient fail to meet these requirements, the award would convert into a loan that must be repaid upon graduation.

The UCR School of Medicine, which opened in 2013, trains a diverse workforce of physicians who seek to improve the health of the medically underserved in the region. About half of the enrolled students come from socioeconomically and/or educationally disadvantaged backgrounds. Approximately a quarter of the medical students are the first in their families to acquire a college degree.

To date, the medical school has graduated four classes totaling 198 students, of which 156 have remained in California. The class of 2020 graduated and took the Hippocratic Oath on May 29.

IEHP is one of the top 10 largest Medicaid health plans and the largest nonprofit Medicare-Medicaid plan in the country. With a network of more than 6,400 providers and more than 2,000 employees, IEHP serves more than 1.2 million residents in Riverside and San Bernardino counties who are enrolled in Medicaid or the Cal MediConnect Plan.

Header image by Elena Zukhova.

Read more:

Gift to School of Medicine aims to alleviate inland Southern California's physician shortage - UC Riverside